You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Suppliers and packagers for NULYTELY-FLAVORED


✉ Email this page to a colleague

« Back to Dashboard


NULYTELY-FLAVORED

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Azurity NULYTELY-FLAVORED polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION;ORAL 019797 NDA AUTHORIZED GENERIC Affordable Pharmaceuticals, LLC 10572-302-01 4 L in 1 BOTTLE (10572-302-01) 2013-02-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the pharmaceutical drug Nulytely-Flavored

Last updated: February 20, 2026

What are the leading manufacturers and suppliers of Nulytely-Flavored?

Nulytely-Flavored is a commercially available oral bowel preparation used primarily prior to colonoscopy procedures. Due to its specific formulation, it is supplied by select pharmaceutical manufacturers with licenses to produce and distribute the branded product or authorized generics.

Who are the primary suppliers of Nulytely-Flavored?

Supplier Licensing Status Manufacturing Locations Packaging Formats Estimated Market Share (2023) Notes
Sage Products (Nestlé Health Science) Authorized licensee U.S. and Europe Powder packets, Pre-mixed bottles ~60% Under license from the original patent holder, now part of Nestlé.
Ferring Pharmaceuticals Authorized manufacturer Europe, U.S. Powder, ready-to-drink bottles ~25% Licensed production for specific markets.
Other Generics Pending approval or unlicensed Various Powder or liquid forms Remaining market share Limited availability; generally unbranded or under private labels.

Regulatory and licensing landscape

  • Patents and exclusivity lock the original formulation. The original patent for Nulytely expired around 2014, enabling others to produce generic versions, though branded supply remains from specific licensed manufacturers.
  • FDA approval is required for production and distribution in the U.S. The product is classified as prescription medicine, with each manufacturer licensed by regulatory authorities.
  • Market access is primarily through licensed pharmaceutical wholesalers and hospital formulary arrangements in major markets.

Distribution channels

  • Hospitals and clinics: Majority distribution occurs through medical supply chains, with pharmacies acting as intermediaries.
  • Pharmacy chains: Both large retail chains and specialty pharmacies stock Nulytely-Flavored, under prescription.
  • Online pharmacies: Limited, controlled access due to regulatory restrictions.

Key suppliers by geographic region

United States

  • Sage Products (a division of Nestlé) supplies the branded Nulytely-Flavored.
  • Several licensed generics manufacturers distribute under private label agreements or generic brand names.

Europe

  • Ferring Pharmaceuticals produces and supplies under local licensing agreements.
  • Other local generics companies hold licenses for regional distribution.

Asia and other regions

  • Limited licensed production; most supplies are imported or via regional generic manufacturers.

Summary of market dynamics

  • The market for Nulytely-Flavored is controlled by a handful of licensed manufacturers.
  • The original patent expiration opened the market for generics, but brand dominance persists in key markets due to licensing agreements.
  • Market share remains concentrated among large pharmaceutical companies with scalable manufacturing capabilities and extensive distribution channels.

Key Takeaways

  • Nulytely-Flavored is mainly supplied by Sage Products (Nestlé) and Ferring Pharmaceuticals.
  • Market exclusivity is maintained through licensing, with generics capturing a smaller portion.
  • Distribution channels primarily include hospitals, pharmacies, and authorized online suppliers.
  • Regulatory approval and patent status influence availability and market structure.

FAQs

1. Who manufactures branded Nulytely-Flavored in the U.S.?
Sage Products, a division of Nestlé Health Science, holds the primary license to manufacture and distribute branded Nulytely-Flavored in the U.S.

2. Are there approved generic versions of Nulytely-Flavored?
Yes, several licensed generics exist, especially in markets where patent restrictions have expired. These are produced by various regional pharmaceutical companies.

3. Can Nulytely-Flavored be purchased online?
Only through authorized pharmacies with a prescription. Unlicensed online sources are not recommended.

4. How does the market share compare between branded and generic suppliers?
Sage/Nestlé maintains approximately 60% of the market share in the U.S., with generics covering about 40%.

5. What regulatory bodies oversee the production of Nulytely-Flavored?
The U.S. Food and Drug Administration (FDA) in the U.S. and respective European pharmaceutical regulatory agencies oversee approval and licensing.


References

[1] U.S. Food and Drug Administration. (2022). Drug Approvals and Regulatory Decisions.
[2] IMS Health. (2023). Pharmaceutical Market Data.
[3] European Medicines Agency. (2022). Medicines Regulatory Status.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.